TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
47 hedge funds and large institutions have $92.9M invested in Telesis Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
50% less capital invested
Capital invested by funds: $187M → $92.9M (-$93.9M)
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.91M | |
| 2 | +$2.13M | |
| 3 | +$774K | |
| 4 |
Goldman Sachs
New York
|
+$705K |
| 5 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
+$276K |
Top Sellers
| 1 | -$6.18M | |
| 2 | -$6.08M | |
| 3 | -$5.44M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$4.59M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$772K |